• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibition.

作者信息

Warn-Cramer B J, Rao L V, Maki S L, Rapaport S I

机构信息

Department of Medicine, University of California, San Diego, La Jolla 92103.

出版信息

Thromb Haemost. 1988 Dec 22;60(3):453-6.

PMID:3238648
Abstract

Inhibition of factor VIIa/tissue factor (TF) by extrinsic pathway inhibitor (EPI) requires the participation of factor Xa. Through this inhibition, factor Xa generated initially may feed back to suppress continuing generation of factor Xa via the extrinsic pathway during hemostasis. We have utilized chemical modifications of EPI and factor Xa to study the reactions responsible for inhibition. The data are consistent with a two-step model. First, EPI binds to factor Xa in a Ca2+ independent reaction in which the gla-domain of factor Xa does not participate. A functional active site on factor Xa and arginine residues on EPI are essential for this step. Then the factor Xa/EPI complex binds to factor VIIa/TF with resultant inhibition of its enzymatic activity. The gla-domain of factor Xa is essential for this step. Intact positively charged lysines on factor Xa may also be important.

摘要

相似文献

1
Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibition.
Thromb Haemost. 1988 Dec 22;60(3):453-6.
2
The lipoprotein-associated coagulation inhibitor.脂蛋白相关凝血抑制剂。
Prog Hemost Thromb. 1991;10:243-68.
3
Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells.
Thromb Haemost. 1989 Feb 28;61(1):101-5.
4
Selective inhibition of factor Xa is more efficient than factor VIIa-tissue factor complex blockade at facilitating coronary thrombolysis in the canine model.
J Am Coll Cardiol. 1996 Dec;28(7):1858-65. doi: 10.1016/S0735-1097(96)00401-9.
5
The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.凝血因子VIIa的催化裂隙和外位点残基在与组织因子途径抑制剂形成复合物中的作用。
Thromb Haemost. 2001 Mar;85(3):458-63.
6
Activity of secreted Kunitz domain 1 variants of tissue factor pathway inhibitor.组织因子途径抑制剂分泌型Kunitz结构域1变体的活性
Thromb Haemost. 1998 Oct;80(4):585-7.
7
Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor.组织因子途径抑制剂对组织因子-因子VIIa的抑制动力学
Thromb Haemost. 1995 Sep;74(3):910-5.
8
Optimization of a coagulation factor VIIa inhibitor found in factor Xa inhibitor library.在Xa因子抑制剂库中发现的凝血因子VIIa抑制剂的优化
Bioorg Med Chem. 2005 Mar 1;13(5):1487-96. doi: 10.1016/j.bmc.2004.12.033.
9
Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor.
Nature. 1989 Apr 6;338(6215):518-20. doi: 10.1038/338518a0.
10
Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.一种与组织因子途径抑制剂同源的新型人Kunitz型蛋白酶抑制剂的抑制特性
Biochemistry. 1996 Jan 9;35(1):266-72. doi: 10.1021/bi951501d.

引用本文的文献

1
Biology of tissue factor pathway inhibitor.组织因子途径抑制物的生物学特性。
Blood. 2014 May 8;123(19):2934-43. doi: 10.1182/blood-2013-11-512764. Epub 2014 Mar 11.
2
Tissue factor pathway inhibitor: structure-function.组织因子途径抑制剂:结构-功能。
Front Biosci (Landmark Ed). 2012 Jan 1;17(1):262-80. doi: 10.2741/3926.
3
Plasma tissue factor pathway inhibitor levels in patients with acute pancreatitis.急性胰腺炎患者血浆组织因子途径抑制物水平
J Gastroenterol. 2009;44(10):1071-9. doi: 10.1007/s00535-009-0096-9. Epub 2009 Jun 30.
4
Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits.组织因子途径抑制剂在兔肾脏中的表达及其在新月体性肾小球肾炎中作用的证据。
J Clin Invest. 1996 Jul 15;98(2):325-35. doi: 10.1172/JCI118796.
5
Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.培养的正常人肝细胞不合成脂蛋白相关凝血抑制剂:内皮是其合成主要部位的证据。
Proc Natl Acad Sci U S A. 1990 Nov;87(22):8869-73. doi: 10.1073/pnas.87.22.8869.
6
Depletion of extrinsic pathway inhibitor (EPI) sensitizes rabbits to disseminated intravascular coagulation induced with tissue factor: evidence supporting a physiologic role for EPI as a natural anticoagulant.外源性途径抑制剂(EPI)的缺失使家兔对组织因子诱导的弥散性血管内凝血敏感:支持EPI作为天然抗凝剂发挥生理作用的证据。
Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):708-12. doi: 10.1073/pnas.88.3.708.